Hi <<First Name>>

Please find your latest copy of the Lab Bulletin Coronavirus (COVID-19) Monthly Update.

This monthly update aims to help keep our readers updated on the latest laboratory products and news for COVID-19 screening and testing.


Here's the latest news for you <<First Name>>

Benchtop FT-NMR Applied to SARS-CoV-2 and ‘Long COVID’ Research Lowers the Barrier to Clinical Translation

Researchers at the Australian National Phenome Centre (ANPC) at Murdoch University have successfully detected and quantified newly discovered biomarkers of SARS-CoV-2 acute infections and of ‘Long COVID’. They used a benchtop Fourier Transform-nuclear magnetic resonance (FT-NMR) spectrometer with a permanent magnet, thereby lowering the barrier to clinical translation of this epidemiological and diagnostic research technology...


How are laboratories tackling misinformation

The COVID-19 pandemic has put a spotlight on the dangers of misinformation in the science industry. This phenomenon has been amplified with the popularity of forums and platforms that act as news distribution networks without a filter or editorial oversight. Here Aleiya Lonsdale, Head of Event at the largest laboratory event in the UK, Lab Innovations 2022,  discusses how the lab community has tried to hold back against the tide of scientific misinformation.


Merck Invests More than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France

Merck, a leading science and technology company, strengthens its manufacturing capabilities for single-use assemblies, a key technology for the production of Covid-19 vaccines and other lifesaving therapies, by investing more than € 130 million in Molsheim, France. The investment is the largest ever in the 50-year history of the site and will create more than 800 jobs by the end of 2028...


New Application Note: COVID-19 agent molnupiravir

Molnupiravir (Lagevrio®) is an antiviral medication to treat mild to medium COVID-19 infection. Molnupiravir is actually a prodrug of the active substrate N4-hydroxycytidine (NHC), a synthetic ribonucleoside analogue. The treatment leads to the introduction of copying errors during viral RNA replication and by this inhibits the viral reproduction. This new Application Note demonstrates how molnupiravir and its active agent β-d-N4-hydroxycytidine can be separated by using a YMC-Triart C18 UHPLC column...


Recent Articles

Benchling Launches the First Complete Solution for RNA R&D to Accelerate mRNA and RNA Therapeutics Development
Infectious disease researchers publish routes to ensure lessons are learned from COVID-19, when using PCR for monkeypox diagnosis
Optimized Lentiviral Vectors to Speed Up Your Research
QIAGEN launches new solutions that significantly accelerate DNA variant detection and RNA sequencing of low-input samples
La Jolla Institute for Immunology Acquires the Carterra LSA Platform to Advance State-of-the-Art Immunological and Infectious Disease Research
Developing a Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene Partnership with Bharat Biotech and the University of Sydney
UK's only WHO accredited vaccine fridge producer secures funding to meet demand for global vaccination programmes
Thermo Fisher Scientific Showcases New Clinical and Research Lab Solutions at AACC 2022
Vaccizone selects Exothera for process development and GMP manufacturing of its SARS‑CoV‑2 vaccine based on proprietary ASC technology
Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for ‘Long COVID’ Multi-Organ Risk Assessment


About Lab Bulletin

Lab Bulletin is a free online resource for scientists and laboratory professionals where you can catch up on the latest news for laboratory products and services. You will also find an extensive directory of laboratory suppliers and manufacturers enabling you to contact companies quickly and easily to request further information.

Lab Bulletin publishes four free monthly newsletters keeping you up-to-date with all of the latest laboratory products and industry news directly to your inbox. In addition to the Coronavirus (COVID-19) Update we have dedicated newsletters for Separation Science, Microscopy & Image Analysis and the Lab Bulletin Monthly Update with a current readership of over 27,000 readers worldwide.

As a subscriber to our Coronavirus (COVID-19) Update, If you would also like to receive a copy of our Separation Science, Microscopy & Image Analysis or the Lab Bulletin monthly newsletter, simply update your
subscription preferences.
Copyright © 2022 Lab Bulletin, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.